feed,title,long_url,short_url
SeekingAlpha,Sangamo begins dosing in trial of TX200 for preventing kidney transplant rejection,https://seekingalpha.com/news/3818525,
SeekingAlpha,WidePoint stock slumps 9% post Q4 results,https://seekingalpha.com/news/3818560,
SeekingAlpha,Meta Materials: Nanotech Acquisition To Add Scale,https://seekingalpha.com/article/4498417,
SeekingAlpha,Celanese Corp. And Its Real Value,https://seekingalpha.com/article/4498416,
